• 3
    Haplo
    Score
  • 0
    Triplo
    Score

Gene Facts External Data Attribution

HGNC Symbol
CDKL5 (HGNC:11411) HGNC Entrez Ensembl OMIM UCSC Uniprot GeneReviews LOVD LSDB ClinVar
HGNC Name
cyclin dependent kinase like 5
Gene type
protein-coding gene
Locus type
gene with protein product
Previous symbols
STK9
Alias symbols
EIEE2, CFAP247
%HI
13.18(Read more about the DECIPHER Haploinsufficiency Index)
pLI
1(Read more about gnomAD pLI score)
LOEUF
0.23(Read more about gnomAD LOEUF score)
Cytoband
Xp22.13
Genomic Coordinates
GRCh37/hg19: chrX:18443728-18671749 NCBI Ensembl UCSC
GRCh38/hg38: chrX:18425608-18653629 NCBI Ensembl UCSC
MANE Select Transcript
NM_001323289.2 ENST00000623535.2 (Read more about MANE Select)
Function
Mediates phosphorylation of MECP2 (PubMed:15917271, PubMed:16935860). May regulate ciliogenesis (PubMed:29420175). {ECO:0000269|PubMed:15917271, ECO:0000269|PubMed:16935860, ECO:0000269|PubMed:29420175}. (Source: Uniprot)

Dosage Sensitivity Summary (Gene)

Dosage ID:
ISCA-14810
ClinGen Curation ID:
CCID:006827
Curation Status:
Complete
Issue Type:
Dosage Curation - Gene
Haploinsufficiency:
Sufficient Evidence for Haploinsufficiency (3)
Triplosensitivity:
No Evidence for Triplosensitivity (0)
Last Evaluated:
07/12/2012

Haploinsufficiency (HI) Score Details

HI Score:
3
HI Evidence Strength:
Sufficient Evidence for Haploinsufficiency (Disclaimer)
HI Disease:
  • developmental and epileptic encephalopathy, 2 Monarch
HI Evidence:
  • PUBMED: 15492925
    Weaving et al. (2004) describe a family consisting of a proband with atypical Rett syndrome (RTT), her identical twin sister with autism and intellectual disability (ID), and a brother with profound ID and seizures. A 1-bp deletion was identified (c.183delT) in CDKL5 resulting in a premature termination in all the affected family members, but not in unaffected members. The proband's unaffected mother tested negative for the mutation and the authors postulate germline mosaicism. Further screening of 44 patients with RTT without a MECP2 mutation revealed one individual with a splice-site mutation (IVS13-1G>A) in CDKL5.
  • PUBMED: 15689447
    Scala et al. (2005) observed two unrelated female patients with infantile spasms, developmental delays, and intellectual disability who fulfilled the criteria for RTT including microcephaly, hand apraxia, generalized hypotonia, and stereotypic hand movements. Sequencing and deletion/duplication analysis of MECP2 was negative. Sequencing of CDKL5 revealed a 4-bp deletion resulting in a premature stop codon in one girl and a 2-bp deletion resulting in a premature stop codon in the second girl.
  • PUBMED: 19241098
    Russo et al. (2008) screened a population of 92 patients with classic or atypical Rett syndrome, 17 Angelman/Angelman-like patients and six with idiopathic autism for mutation in CDKL5. Six CDKL5 mutations were identified in the Rett subset including 2 missense mutations, 2 splicing mutations, a nonsense mutation, and a two exon deletion. An additional insertion mutation was identified in a patient with features consistent with a clinical diagnosis of Angelman syndrome.
HI Evidence Comments:
Mutations in CDKL5 are associated with an atypical variant of Rett syndrome, which includes intellectual disability and severe neurological symptoms. Characteristics include severe early-onset seizures, loss of communication and motor skills, hypsarrythmia, and profound global developmental arrest. Hand-wringing and hand-mouthing stereotypies and breathing dysfunction suggestive of Rett syndrome have been reported.
NOTE:

The loss-of-function and triplosensitivity ratings for genes on the X chromosome are made in the context of a male genome to account for the effects of hemizygous duplications or nullizygous deletions. In contrast, disruption of some genes on the X chromosome causes male lethality and the ratings of dosage sensitivity instead take into account the phenotype in female individuals. Factors that may affect the severity of phenotypes associated with X-linked disorders include the presence of variable copies of the X chromosome (i.e. 47,XXY or 45,X) and skewed X-inactivation in females.

Triplosensitivity (TS) Score Details

TS Score:
0
TS Evidence Strength:
No Evidence for Triplosensitivity (Disclaimer)
NOTE:

The loss-of-function and triplosensitivity ratings for genes on the X chromosome are made in the context of a male genome to account for the effects of hemizygous duplications or nullizygous deletions. In contrast, disruption of some genes on the X chromosome causes male lethality and the ratings of dosage sensitivity instead take into account the phenotype in female individuals. Factors that may affect the severity of phenotypes associated with X-linked disorders include the presence of variable copies of the X chromosome (i.e. 47,XXY or 45,X) and skewed X-inactivation in females.

Genomic View

Select assembly: (NC_000023.10) (NC_000023.11)